Autoantigen characterization in liver/kidney microsome positive hepatitis (Q34024689)

30 July 2017

1 reference

title

Autoantigen characterization in liver/kidney microsome positive hepatitis (English)

1 reference

30 July 2017

Clemente MG

1

1 reference

30 July 2017

De Virgiliis S

series ordinal

2

1 reference

30 July 2017

publication date

1 January 2000

1 reference

Digestive and Liver Disease

30 July 2017

published in

1 reference

30 July 2017

volume

32

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

39-45

1 reference

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: Model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Coeliac disease hidden by cryptogenic hypertransaminasaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Autoimmune polyendocrinopathy--candidiasis--ectodermal dystrophy (APECED).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980043-2

7 January 2021

10.1016/S1590-8658(00)80043-2

Identifiers

DOI

1 reference

30 July 2017

1 reference